Chronic Illness

作者须在投稿过程中列出每位作者的具体贡献，并在稿件中致谢部分之后加入“作者贡献”标题，该信息将在校对阶段显示于该标题之下。 模型中文摘要

You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.

期刊鼓励作者在符合伦理和法律要求的前提下，将研究数据存入相关公共数据仓库、提供链接数据的数据可用性声明（无法共享时须说明原因）并在研究中引用该数据。 模型中文摘要

The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…

作者须在该标题下提供伦理批准声明（即使方法部分已写明）；若无需伦理批准也须明确说明；涉及人类参与者、人类数据或人体组织的研究须注明伦理委员会或机构审查委员会批准或豁免，并给出委员会全称、所属机构及批准编号。 模型中文摘要

Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…

向该期刊投稿或发表无需支付任何费用；彩色图片在线免费显示，但应要求在印刷版再现彩色时须付费（首图300英镑，其后每图100英镑）；作者也可通过Sage Choice计划或开放获取协议付费选择开放获取。 模型中文摘要

There are no fees payable to submit or publish in this journal. Figures supplied in colour will appear in colour online regardless of whether or not these illustrations are reproduced in colour in the printed version. For specifically requested colour reproduction in print, you will receive information regarding the costs from Sage after receipt of your accepted article. Production confirmed that …

该期刊采用双匿名同行评审，稿件先经初步评估（不符合要求可退回修改或直接拒稿），通过后由编辑分派给副编辑遴选审稿人，审稿意见经副编辑建议后由编辑作最终决定，且不公布审稿信息。 模型中文摘要

The following summary describes the peer review process for this journal: Identity transparency: Double-anonymized Reviewer interacts with: Editor assigns manuscripts to AEs who then select reviewers. After review, AEs make recommendations to Editor, who then makes the final decision on all manuscripts. Review information published: None Your manuscript will undergo an initial evaluation. If it do…

期刊和Sage严肃对待版权侵犯、抄袭及其他违反出版最佳实践的行为，并请作者阅读Sage完整的抄袭政策及可能采取的措施。 模型中文摘要

The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.

该期刊不接受已在预印本服务器上发布过的稿件投稿。 模型中文摘要

The journal does not accept submissions of manuscripts that have been posted on preprint servers.

依据ICMJE要求，临床试验须在招募首名参与者之前或当时在WHO认可的公共试验注册机构注册，作为考虑发表的先决条件，且须在摘要末尾注明注册机构名称、网址及注册号。 模型中文摘要

The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.